Hospital Ward Malaria Treatment Prescription
For Uncomplicated Malaria (P. falciparum)
Artemether-Lumefantrine (Coartem) is the first-line treatment for uncomplicated malaria in hospitalized patients, with cure rates exceeding 95%. 1, 2
Standard Adult Regimen:
- Artemether-Lumefantrine 20/120 mg tablets:
Alternative First-Line Option:
- Dihydroartemisinin-Piperaquine:
Second-Line (if ACTs contraindicated):
Atovaquone-Proguanil (Malarone):
- 4 tablets once daily for 3 days
- Take with fatty meal 1
Quinine Sulfate 648 mg (two capsules) every 8 hours for 7 days PLUS Doxycycline 100 mg twice daily for 7 days (if patient ≥8 years old) 4, 5
For Severe Malaria
Intravenous Artesunate is the only acceptable first-line treatment for severe malaria, as delayed treatment significantly increases mortality. 1, 2, 3
IV Artesunate Regimen:
- 2.4 mg/kg IV at 0,12, and 24 hours
- Then 2.4 mg/kg IV once daily until parasitemia <1% and patient can tolerate oral medication 1, 2
- Monitor parasitemia every 12 hours until <1%, then every 24 hours until negative 1, 3
Transition to Oral Therapy:
- Once parasitemia <1% and patient tolerates oral intake: Complete full 3-day course of Artemether-Lumefantrine (as above) 1, 2
For Non-Falciparum Malaria (P. vivax, P. ovale, P. malariae)
In Chloroquine-Sensitive Regions:
- Chloroquine:
Followed by Radical Cure (P. vivax/P. ovale only):
- MUST test for G6PD deficiency first 2, 3
- If G6PD normal: Primaquine 30 mg base daily for 14 days 2
- If G6PD deficiency (30-70% activity): Primaquine 45 mg once weekly for 8 weeks 2
Special Populations
Pregnant Women:
- Second and Third Trimester: Artemether-Lumefantrine (same dosing as above) 6, 1, 2
- First Trimester (if no alternatives): Quinine 648 mg every 8 hours for 7 days PLUS Clindamycin 300 mg every 8 hours for 7 days 3
Renal Impairment (if using Quinine):
- Loading dose: 648 mg once
- Maintenance: 324 mg every 12 hours (starting 12 hours after loading dose) 4
Critical Monitoring Requirements
Post-Treatment Monitoring:
- Check for post-artemisinin delayed hemolysis (PADH) on days 7,14,21, and 28 after treatment 1, 2, 3
- Monitor hemoglobin/hematocrit at these intervals, as PADH occurs in 37.4% of patients 2
Drug Interactions and Contraindications:
- Both Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine prolong QTc interval - avoid in patients with QTc prolongation risk or on QTc-prolonging medications 1, 2, 3
- Primaquine and Tafenoquine are absolutely contraindicated in pregnancy 2
Common Pitfalls to Avoid
- Failure to administer Artemether-Lumefantrine with fatty food results in subtherapeutic levels and treatment failure - this is the most common error 1, 2, 3
- Do NOT give Dihydroartemisinin-Piperaquine with food - it must be taken fasting 1, 2
- Never delay treatment while awaiting confirmatory testing in suspected severe malaria - mortality increases significantly with delays 1, 3
- Always complete the full oral ACT course after IV artesunate, even if patient appears clinically well 1, 2